Ann Dermatol.  2014 Jun;26(3):424-425.

Gene Mutation Analysis in a Korean Patient with Early-Onset and Recalcitrant Generalized Pustular Psoriasis

• Song HS
• Yun SJ
• Park S
• Lee ES

Abstract

No abstract available.

MeSH Terms

Humans
Psoriasis*

Figure

• 

  Fig. 1 More extensive and aggressive pustular patches (A) covering >90% of the body surface area compared to those observed in the previous attack (B).

• 

  Fig. 2 Mutation c.115+6T>C observed in a Korean patient (A). At the protein level, a higher expression of interleukin-36 (IL-36) is noted on keratinocytes below the pustules (B) compared to those of psoriasis vulgaris (C) (B, C: polyclonal anti-IL-36α/IL-1F6 antibody, ×200)

Reference

1. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007; 370:263–271.

2. Marrakchi S, Guigue P, Renshaw BR, Puel A, Pei XY, Fraitag S, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011; 365:620–628.

3. Onoufriadis A, Simpson MA, Pink AE, Di Meglio P, Smith CH, Pullabhatla V, et al. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet. 2011; 89:432–437.

4. Farooq M, Nakai H, Fujimoto A, Fujikawa H, Matsuyama A, Kariya N, et al. Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis. Hum Mutat. 2013; 34:176–183.

5. Debets R, Timans JC, Homey B, Zurawski S, Sana TR, Lo S, et al. Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J Immunol. 2001; 167:1440–1446.